Understanding your diagnosis
Type 2 diabetes means your body is either not producing enough insulin or not using it effectively — resulting in higher than normal blood glucose levels. Left unmanaged, high blood glucose damages blood vessels and nerves over time, affecting the kidneys, eyes, heart, and feet.
The good news: Type 2 diabetes is one of the most manageable chronic conditions when tracked correctly. The difference between "managed" and "well-managed" is knowing which numbers to watch and what to do when they move.
How diabetes is diagnosed in Canada
Three tests are used, any one of which can confirm a diagnosis:
| Test | Normal | Pre-diabetes | Diabetes |
|---|---|---|---|
| Fasting blood glucose | Below 6.1 mmol/L | 6.1–6.9 mmol/L | 7.0 mmol/L or higher |
| 2-hour glucose (after 75g glucose) | Below 7.8 mmol/L | 7.8–11.0 mmol/L | 11.1 mmol/L or higher |
| HbA1c | Below 6.0% | 6.0–6.4% | 6.5% or higher |
| Random blood glucose (with symptoms) | — | — | 11.1 mmol/L or higher |
Source: Diabetes Canada Clinical Practice Guidelines 2023
The biomarkers that actually matter
Not all lab values are equally important. Here are the ones your specialist will focus on, in order of importance:
1. HbA1c (Glycated Hemoglobin)
The single most important number in diabetes management. It reflects your average blood glucose over the past 2–3 months. Unlike a fasting glucose test, it cannot be manipulated by what you ate the day before.
2. Fasting blood glucose
Your blood glucose after at least 8 hours without eating. Checked regularly to track day-to-day control.
3. Post-meal glucose (2-hour postprandial)
Blood glucose measured 2 hours after starting a meal. Often more revealing than fasting glucose for people whose HbA1c is borderline.
4. Kidney function — eGFR and urine ACR
Diabetes is the leading cause of kidney disease in Canada. eGFR (estimated glomerular filtration rate) and urine albumin-to-creatinine ratio (ACR) must be checked annually — more often if abnormal.
5. Lipid panel
People with diabetes have significantly higher cardiovascular risk. LDL, HDL, triglycerides, and total cholesterol should be checked at least annually.
6. Blood pressure
Target for most people with diabetes: below 130/80 mmHg. Hypertension and diabetes together multiply cardiovascular and kidney risk.
7. Eye exam (retinal screening)
Annual dilated eye exam to check for diabetic retinopathy. Often delayed in Canada due to wait times — do not skip this.
8. Foot exam
Annual comprehensive foot exam to check sensation, circulation, and skin integrity. Loss of sensation (neuropathy) is common and often unnoticed until serious.
9. Vitamin B12
If you take Metformin, B12 levels should be checked annually — Metformin depletes B12 over time, causing neuropathy that can be mistaken for diabetic nerve damage.
10. Thyroid function (TSH)
Thyroid disease is significantly more common in people with Type 2 diabetes. TSH should be checked at diagnosis and every 1–2 years.
11. Fasting Insulin
Rarely ordered by Canadian GPs but highly informative. Fasting insulin tells you how hard your pancreas is working to keep your glucose normal. High fasting insulin (above 60–70 pmol/L) with normal glucose indicates significant insulin resistance — the body is compensating. Used alongside fasting glucose to calculate HOMA-IR.
Normal range: 18–60 pmol/L (fasting)
Ask your doctor: "Can we check my fasting insulin alongside my next fasting glucose?"
12. HOMA-IR (Insulin Resistance Score)
Calculated from fasting glucose and fasting insulin. Quantifies how insulin resistant you are. Not a standard Canadian lab test — your doctor calculates it or you can calculate it yourself:
Interpretation:
- Below 1.5: Normal insulin sensitivity
- 1.5–2.5: Mild insulin resistance
- Above 2.5: Significant insulin resistance — warrants medication review
- Above 5.0: Severe insulin resistance
13. HOMA-Beta (Beta Cell Function)
Calculated alongside HOMA-IR. Estimates how much functional capacity your insulin-producing beta cells have remaining. Declining HOMA-Beta over time indicates progressive beta cell exhaustion — a signal that oral medications may eventually need to be supplemented with insulin.
Normal: Above 100%
Below 50%: Significant beta cell loss — specialist review recommended
Why this matters: Most Canadian GPs do not routinely check fasting insulin, HOMA-IR, or HOMA-Beta. A specialist will use these to understand whether you have primarily an insulin resistance problem (more responsive to lifestyle and sensitizers like Metformin) or a beta cell failure problem (more likely to need insulin or GLP-1 therapy sooner). Getting these tests can fundamentally change your treatment plan.
Continuous Glucose Monitoring (CGM) — the most underused tool in Canadian diabetes care
A CGM (such as Libre 3 or Dexcom G7) measures your blood glucose every few minutes and shows you a continuous curve — not just a snapshot. Available in Canada; partially covered in some provinces for Type 1, mostly out-of-pocket for Type 2 (~$80–120/month).
What a CGM tells you that finger-prick testing cannot:
- Your glucose curve after every meal — which foods spike you and which don't
- Whether you drop low overnight (common, often undetected)
- The effect of exercise, stress, and sleep on your glucose in real time
- Time-in-Range (TIR) — the percentage of time your glucose stays between 3.9 and 10.0 mmol/L. Target: above 70% for most adults.
- Glucose variability — high variability even within "normal" ranges is an independent risk factor
How specialists use CGM data:
- To titrate insulin doses precisely (especially basal insulin)
- To identify post-meal spikes that HbA1c misses
- To diagnose nocturnal hypoglycemia
- To motivate and guide lifestyle changes with real-time feedback
If you have access to a CGM, download 2 weeks of data before any specialist consultation — it provides more actionable information than months of finger-prick logs.
The Ginie Health app can import your Libre or Dexcom data and display your Time-in-Range trends alongside your other biomarkers.
Your Canadian lab results explained (mmol/L)
Canada uses mmol/L for blood glucose (not mg/dL used in the US). Here is what your numbers mean:
HbA1c targets
| HbA1c | What it means |
|---|---|
| Below 6.5% | Excellent control — near-normal glucose levels |
| 6.5–7.0% | Good control — target for most adults with diabetes |
| 7.0–7.5% | Acceptable — room for improvement |
| 7.5–8.5% | Suboptimal — increased risk of complications |
| Above 8.5% | Poor control — significant risk, action needed |
Note: Targets may be individualized. Older adults or those with frequent hypoglycemia may have a target of 7.1–8.5%.
Fasting blood glucose targets
| Reading | Interpretation |
|---|---|
| 4.0–7.0 mmol/L | Target range for most people with diabetes |
| Below 4.0 mmol/L | Hypoglycemia — too low, potentially dangerous |
| 7.1–10.0 mmol/L | Above target — review medications and diet |
| Above 10.0 mmol/L | Significantly elevated — contact your doctor |
2-hour post-meal glucose targets
| Reading | Interpretation |
|---|---|
| Below 8.5 mmol/L | Excellent post-meal control |
| 8.5–10.0 mmol/L | Acceptable |
| Above 10.0 mmol/L | Post-meal spikes — review meal composition |
Kidney function
| Test | Normal | Concern | Action needed |
|---|---|---|---|
| eGFR | Above 90 | 60–89 (mild reduction) | Below 60 |
| Urine ACR | Below 2.0 mg/mmol | 2.0–20 (microalbuminuria) | Above 20 |
Lipids (with diabetes, targets are stricter)
| Test | Target with diabetes |
|---|---|
| LDL cholesterol | Below 2.0 mmol/L |
| HDL (men) | Above 1.0 mmol/L |
| HDL (women) | Above 1.3 mmol/L |
| Triglycerides | Below 1.7 mmol/L |
| Total cholesterol | Below 4.0 mmol/L |
Understanding modern diabetes medications — and how to personalize your treatment
Diabetes medication has changed dramatically in the last decade. The old model — Metformin, then sulfonylureas, then insulin — is being replaced by a more nuanced, personalized approach. Here is what you need to know.
Metformin — still the foundation
Metformin remains the first-line medication for most people with Type 2 diabetes. It reduces liver glucose production, improves insulin sensitivity, is weight-neutral, costs almost nothing, and has decades of safety data. Unless you have kidney impairment (eGFR below 30) or cannot tolerate it, Metformin is almost always part of the regimen.
Important: Metformin depletes Vitamin B12. Check B12 annually.
GLP-1 Receptor Agonists — the most important class of the decade
GLP-1 agonists (semaglutide/Ozempic/Wegovy, liraglutide/Victoza, dulaglutide/Trulicity, tirzepatide/Mounjaro) have transformed diabetes care. They work by:
- Stimulating insulin release only when glucose is high (low hypoglycemia risk)
- Suppressing glucagon (which raises glucose)
- Slowing gastric emptying (reducing post-meal spikes)
- Reducing appetite significantly (leading to meaningful weight loss)
- Providing proven cardiovascular and kidney protection
Who benefits most from GLP-1s:
- People with obesity and Type 2 diabetes (weight loss benefit is substantial)
- People with established cardiovascular disease or high CV risk
- People with early kidney disease (nephroprotective effect)
- People whose HbA1c is not at target despite Metformin
Side effects: nausea (usually improves after 4–8 weeks), vomiting, reduced appetite. Rare: pancreatitis. Not recommended in personal or family history of thyroid cancer.
In Canada: Ozempic (semaglutide 0.5–2mg weekly injection) and Trulicity (dulaglutide weekly injection) are most commonly prescribed. Mounjaro (tirzepatide) — a dual GLP-1/GIP agonist — shows even greater HbA1c reduction and weight loss than semaglutide alone and is now available in Canada.
SGLT2 Inhibitors — for kidneys and heart
Empagliflozin (Jardiance), dapagliflozin (Farxiga), canagliflozin (Invokana) work by making the kidneys excrete excess glucose in urine. Benefits:
- HbA1c reduction of 0.5–1.0%
- Weight loss of 2–4 kg
- Blood pressure reduction
- Proven reduction in cardiovascular events and hospitalization for heart failure
- Significant kidney protection (now used even in non-diabetic kidney disease)
Who benefits most: people with heart failure, established cardiovascular disease, or chronic kidney disease. Often combined with GLP-1 agonists for additive effect.
Side effects: genital yeast infections, UTIs, rare risk of DKA (stop before surgery or prolonged fasting).
DPP-4 Inhibitors — modest but well-tolerated
Sitagliptin (Januvia), saxagliptin (Onglyza). Older class, modest HbA1c reduction (~0.5%), weight-neutral, very well tolerated. Being used less frequently now that GLP-1s and SGLT2s have stronger evidence. Still useful for older patients or those who cannot tolerate other agents.
Sulfonylureas — effective but carry hypoglycemia risk
Glyburide, gliclazide (Diamicron). Stimulate insulin release regardless of glucose level — meaning they can cause hypoglycemia, especially if meals are skipped. Cause weight gain. Still widely used in Canada due to low cost. If you are on a sulfonylurea and experiencing hypoglycemia, ask your doctor whether a safer alternative is appropriate.
Insulin — when and how
Insulin is not a failure. It is a highly effective tool that many people need as diabetes progresses and beta cell function declines.
Types of insulin used in Canada:
- Basal insulin (glargine/Lantus, degludec/Tresiba): once-daily injection, controls fasting glucose overnight and between meals
- Rapid-acting insulin (lispro/Humalog, aspart/NovoRapid, glulisine/Apidra): taken with meals to control post-meal spikes
- Premixed insulin (combines basal and rapid): once or twice daily, less flexible but simpler
How to inject insulin:
- Use the abdomen (fastest absorption), thigh (moderate), or upper arm (slowest) — rotate sites to prevent lipohypertrophy (hard lumps that reduce absorption)
- Inject into subcutaneous fat, not muscle — pinch skin if thin
- Use a fresh needle every time — reusing needles causes pain and inaccurate dosing
- Store unopened insulin in the fridge; opened vials/pens at room temperature for up to 28–30 days
- Do not inject into areas of lipohypertrophy
How GLP-1s have changed insulin use: GLP-1 agonists significantly reduce the amount of insulin needed — some people can reduce or discontinue insulin after starting a GLP-1. This combination (basal insulin + GLP-1) is now one of the most effective regimens available, producing HbA1c reductions of 1.5–2.5%.
Personalizing your medication — what a specialist looks for
A Canadian GP typically follows a standard escalation protocol. An endocrinologist personalizes based on:
- Your HOMA-IR and HOMA-Beta (resistance vs. beta cell failure)
- Your cardiovascular and kidney risk profile
- Your weight trajectory
- Your glucose pattern (fasting high vs. post-meal high vs. both)
- Your tolerance and lifestyle
- Your other medications and conditions
This personalization is why specialist input matters — the right combination for a 45-year-old with obesity and high CV risk is very different from the right combination for a 70-year-old with kidney disease and low BMI.
Recognizing and managing hypoglycemia and hyperglycemia
Hypoglycemia (low blood sugar) — below 4.0 mmol/L
Symptoms: shakiness, sweating, rapid heartbeat, dizziness, anxiety, confusion, pale skin, hunger, headache. Severe: confusion, seizure, loss of consciousness.
Causes: too much insulin or sulfonylurea medication, skipped or delayed meals, more physical activity than usual, alcohol without food.
Treatment — the 15-15 rule:
- Take 15 grams of fast-acting carbohydrate:
- 4 glucose tablets (preferred)
- 125 mL (½ cup) of fruit juice or regular soda
- 1 tablespoon of honey or sugar
- Wait 15 minutes and recheck blood glucose
- If still below 4.0 mmol/L, repeat
- Once glucose is above 4.0 mmol/L, eat a small snack containing carbohydrate and protein if your next meal is more than 1 hour away
Do NOT: use chocolate, cookies, or fatty foods — fat slows glucose absorption.
When to call 911: if the person is unconscious or cannot swallow.
Preventing hypoglycemia:
- Never skip meals if on insulin or sulfonylurea
- Carry glucose tablets at all times
- Check glucose before driving
- Reduce insulin dose proactively before planned exercise
- Avoid alcohol on an empty stomach
Nocturnal hypoglycemia (low glucose overnight): Often undetected. Symptoms: waking with headache, night sweats, feeling unrefreshed. A CGM will catch this. If suspected, check glucose at 2–3am or use a CGM.
Hyperglycemia (high blood sugar) — consistently above 10 mmol/L
Symptoms: increased thirst, frequent urination, fatigue, blurred vision, slow-healing wounds, headache.
Causes: missed medications, illness or infection, stress (physical or emotional), high-carbohydrate meals, inactivity, steroid medications.
What to do:
- Check your glucose and note the reading
- Drink water (helps kidneys flush excess glucose)
- Take your medication if you missed a dose (follow your doctor's guidance on what to do if a dose is missed)
- Avoid high-carbohydrate foods until glucose returns to range
- If above 14 mmol/L and not coming down: contact your doctor or diabetes educator
- If above 20 mmol/L or you have symptoms of DKA (nausea, vomiting, fruity breath, deep breathing, confusion): go to emergency immediately
Diabetic Ketoacidosis (DKA) — rare in Type 2, more common in Type 1, but can occur in Type 2 under severe stress or illness, or in those on SGLT2 inhibitors. Always a medical emergency.
What good diabetes control looks like
Good control is not just a number. Here is what "well-managed" diabetes looks like in practice:
- HbA1c at or below your personal target (usually 7.0%)
- Fasting glucose consistently 4.0–7.0 mmol/L
- Post-meal glucose below 8.5 mmol/L at 2 hours
- Blood pressure below 130/80 mmHg
- LDL below 2.0 mmol/L
- eGFR stable (not declining year over year)
- Urine ACR below 2.0 mg/mmol
- No hypoglycemic episodes (blood sugar below 4.0 mmol/L)
- Stable weight or gradual progress toward a healthy weight
- No symptoms: excessive thirst, frequent urination, fatigue, blurred vision, slow-healing wounds
If you are hitting all of these, your care plan is working. If three or more are off target, your plan needs review.
What to track every day, week, and month
Every day
- Blood glucose (fasting, if recommended by your doctor)
- Blood glucose 2 hours after meals (if your doctor has advised this)
- Any symptoms: unusual fatigue, thirst, frequent urination, dizziness, sweating
- Medications taken (yes/no)
- Meals — general composition, not calorie counting
Every week
- Weight (same time, same scale, same conditions)
- Average blood glucose readings — look for patterns
- Physical activity minutes
- Sleep quality (poor sleep raises blood glucose)
Every 3 months (at your diabetes appointment)
- HbA1c
- Blood pressure
- Weight and waist circumference
- Medication review
- Foot check
Every year
- Full lipid panel
- Kidney function (eGFR + urine ACR)
- Liver function (ALT — especially if on medications)
- Thyroid function (TSH)
- Vitamin B12 (if on Metformin)
- Dilated eye exam (retinal screening)
- Comprehensive foot exam
- Dental exam (diabetes increases gum disease risk)
Tracking tools: The Ginie Health app tracks all of these automatically — log your readings, upload your lab reports, and see whether your numbers are trending in the right direction. Download the app →
When your care plan isn't working
Your care plan needs review if:
Your HbA1c is not improving after 3 months
A medication or lifestyle adjustment should produce a measurable improvement in HbA1c within 3 months. If it hasn't moved, the plan needs to change — not more waiting.
Your fasting glucose is consistently above 7.0 mmol/L
Especially if your HbA1c is also above target. This suggests inadequate overnight control — often addressed by adjusting evening medications or meal timing.
Your post-meal glucose spikes above 10 mmol/L regularly
Post-meal spikes are often under-managed in Canadian primary care. A specialist may recommend adding a medication specifically targeting post-meal glucose (e.g. an SGLT2 inhibitor or GLP-1 agonist).
Your kidney function is declining
A drop in eGFR of more than 5 points per year, or rising urine ACR, requires urgent specialist review. Some common diabetes medications need dose adjustment or discontinuation as kidney function declines.
You are experiencing hypoglycemia
Episodes of blood glucose below 4.0 mmol/L — especially if frequent or severe — indicate over-medication or erratic eating patterns. This needs immediate attention.
You have been waiting more than 6 months to see an endocrinologist
This is common in Canada. In the meantime, a specialist second opinion can give you a clear assessment of whether your current plan is appropriate and what changes should be made.
The Canadian endocrinologist wait time reality
Wait times for an endocrinologist in Canada vary significantly by province:
- British Columbia: 6–18 months in many regions
- Ontario: 4–12 months depending on city
- Alberta: 3–9 months
- Quebec: 6–12 months
- Rural areas: often no local endocrinologist available
These are not exceptional cases — they are the norm. If your GP refers you today, you may not see a specialist until next year.
What to do while you wait:
- Ask your GP to optimize your current regimen as much as possible — bring this guide to your appointment
- Get a specialist second opinion through Ginie Health — Dr. Bhansali will review your full history, assess your current medications, and give you a clear written opinion on what should change and why. Within 24 hours, not 12 months.
- Use the time to get the tests that matter: fasting insulin, HOMA-IR, urine ACR, lipids, B12, eye exam
- Track your glucose carefully so you have data to show when you finally see the specialist
Questions to ask your doctor
At every diabetes appointment, ask:
- What is my HbA1c today, and what is my personal target?
- Is my kidney function stable compared to last year?
- Are my lipids at target given that I have diabetes?
- Should I be checking my blood glucose at home, and if so, when and how often?
- Is my current medication regimen the best option for me, given my other conditions?
- What outcome are we trying to achieve in the next 3 months, and how will we measure it?
- Do I need a referral to an endocrinologist?
If your doctor cannot answer question 6 specifically — what outcome, measured how, by when — that is a signal that your care could be more structured.
What we have seen at Gini Advanced Care Hospital, Mohali
At Gini Advanced Care Hospital, we manage hundreds of patients with Type 2 diabetes annually across Chandigarh, Mohali, and the tricity region. A few patterns we see consistently:
Most patients arrive undertreated. The majority of patients referred to us have HbA1c values between 8.5–11% despite being on Metformin for years. The most common reason: no specialist review, no medication adjustment, no HOMA-IR assessment to understand whether the patient has insulin resistance or beta cell failure — and therefore no personalization of treatment.
GLP-1s are underutilized in India and in the diaspora. In our experience, adding a GLP-1 agonist to patients with HbA1c above 8% and significant insulin resistance produces HbA1c reductions of 1.5–2.5 percentage points within 3–6 months — without increasing hypoglycemia risk. The weight loss benefit is an added motivator for compliance.
Personalization consistently outperforms protocol. Patients treated with a personalized regimen based on their HOMA-IR, HOMA-Beta, glucose pattern, and comorbidities achieve target HbA1c significantly faster than those on a standard escalation protocol. There is no single right medication combination — the right one depends on your specific physiology.
We tell every patient the same thing: compliance with the wrong plan will not get you where you need to be. Get the right plan first.
When to get a specialist opinion
Consider a specialist second opinion if:
- Your HbA1c has been above 7.5% for more than 6 months despite medication
- You have been diagnosed with diabetes complications (kidney disease, retinopathy, neuropathy)
- You are on three or more diabetes medications and your numbers are still not at target
- You are experiencing frequent hypoglycemia
- You are pregnant or planning pregnancy with diabetes
- You were recently diagnosed and want a comprehensive plan from a specialist, not just a prescription
- You are waiting months to see a Canadian endocrinologist and need guidance now
Get a specialist opinion on your diabetes — within 24 hours
Dr. Anil Bhansali has over 30 years of experience managing complex diabetes and endocrine conditions at PGIMER Chandigarh — one of India's leading medical institutions. A written specialist opinion is $45 CAD. A video consultation is $75 CAD.
Upload your recent lab reports and our specialist will review your full history. Opinion delivered within 24 hours.
This guide is for informational purposes only and does not constitute medical advice. All blood glucose and biomarker targets are based on Diabetes Canada Clinical Practice Guidelines (2023) and should be individualized with your healthcare provider. If you are experiencing a medical emergency, call 911.